Pralatrexate for refractory or recurrent subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic syndrome - 09/01/20
Doi : 10.1016/j.jaad.2019.07.021
Olivia Ware, BA a, Erica S. Tarabadkar, MD b, Andrei Shustov, MD c, Michi M. Shinohara, MD b, d, ⁎ 
a Howard University College of Medicine, Washington, DC
b Division of Dermatology, Department of Medicine, University of Washington, Seattle, Washington
c Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington
d Division of Dermatopathology, Department of Pathology, University of Washington, Seattle, Washington
∗Correspondence to: Michi M. Shinohara, MD, 1959 NE Pacific St, Box 356524 BB1332E, Division of Dermatology, University of Washington, Seattle, Washington 981951959 NE Pacific St, Box 356524 BB1332EDivision of Dermatology, University of WashingtonSeattleWashington98195
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB status: The University of Washington Human Subjects Division reviewed this research and determined it exempt (STUDY00003186). |
|
| Reprints not available from the authors. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 2
P. 489-491 - février 2020 Retour au numéro
Article précédent
- Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers
- Michele Z. Magnino, David J. Perry, Deepa S. Subramaniam, Cynthia M.C. DeKlotz
- Thyroid disorders in patients with hidradenitis suppurativa: A systematic review and meta-analysis
- Prakash Acharya, Mahesh Mathur
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?